Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease

समान संसाधन

• AB083. TEW-7197, a novel orally bioavailable activin receptor-like kinase 5 inhibitor, promotes regression of fibrotic plaque in a rat model of Peyronie’s disease
  द्वारा: Song, Kang-Moon, और अन्य
  प्रकाशित: (2018)
• Activin Receptor-Like Kinase 5 Inhibitor Attenuates Fibrosis in Fibroblasts Derived from Peyronie's Plaque
  द्वारा: Jang, Jin Hyuk, और अन्य
  प्रकाशित: (2012)
• Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque
  द्वारा: Kang, Dong Hyuk, और अन्य
  प्रकाशित: (2018)
• Three-Dimensional Reconstruction of Neurovascular Network in Whole Mount Preparations and Thick-Cut Transverse Sections of Mouse Urinary Bladder
  द्वारा: Nguyen, Nhat Minh, और अन्य
  प्रकाशित: (2021)
• Gene expression profiling of mouse cavernous endothelial cells for diagnostic targets in diabetes-induced erectile dysfunction
  द्वारा: Yin, Guo Nan, और अन्य
  प्रकाशित: (2021)